Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oralair in Children With Grass Pollen Rhinoconjunctivitis
NCT00409409Phase 3Completed
- Sponsor
- Stallergenes Greer
- Start
- Dec 2006
- Primary completion
- Sep 2007
- Countries
- 1
01
Overview
A Phase 3 trial of Oralair in allergic rhinoconjunctivitis (ARC), sponsored by Stallergenes Greer. Started Dec 2006; status: completed.
02
Drugs
Oralair
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT00409409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409409.